Home » Epiphany: Phase IIb Shingles Trial Yields Positive Results
Epiphany: Phase IIb Shingles Trial Yields Positive Results
Epiphany Biosciences announced results from its Phase 2b dose-ranging study
of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection.
redOrbit
redOrbit
Upcoming Events
-
07May
-
14May
-
30May